Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
KP
Kiora Pharmaceuticals, Inc. Common Stock
KPRX
Mkt Cap
$10.6M
Volume
11.57K
Next Earnings
November 6th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
KP
KPRX
KP
Kiora Pharmaceuticals, Inc. Common Stock
KPRX
News
·
Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight
Mkt Cap
$10.7M
Volume
11.57K
Next Earnings
November 6th
Chart
Financials
Earnings
News
About
Insider
Filings
Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight
The article discusses the advancements in gene therapy for Stargardt disease, a genetic eye disorder, and highlights the significant investment and interest in developing long-term treatments. It mentions over 20 companies working on 25+ pipeline drugs to improve the treatment landscape.
GlobeNewswire Inc. · Nov 19, 2024
Is Kiora Pharmaceuticals (KPRX) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research · Jun 18, 2024
HC Wainwright & Co. Maintains Buy Rating for Kiora Pharmaceuticals: Here's What You Need To Know
HC Wainwright & Co. has decided to maintain its Buy rating of Kiora Pharmaceuticals (NASDAQ:KPRX) and raise its price target from $3.50 to $2.00. Shares of Kiora Pharmaceuticals are trading down 0.84% over the last 24 hours, at $0.66 per share. A move to $2.00 would account for a 202.57% increase from the current share price. About Kiora Pharmaceuticals Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. It operates in ...Full story available on Benzinga.com
Benzinga · Feb 9, 2024
Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results. Skechers said fourth-quarter revenue increased 4.4% year-over-year to $1.96 billion, which missed the consensus estimate of $2.03 billion, according to Benzinga Pro. The company reported quarterly earnings of 56 cents per share, which beat analyst estimates of 54 cents per share. Skechers shares fell 6.9% to $59.21 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares jumped 77.6% to $4.28. Intelligent Bio Solutions said it sees preliminary second-quarter revenue of $0.76 million. Minim, Inc. (NASDAQ: MINM) shares rose 34.4% to $6.76 after gaining more than 22% on Thursday. Remark Holdings, Inc. (NASDAQ: MARK) shares climbed 33% to $0.6802. Kopin Corporation (NASDAQ: KOPN) jumped 30% to $2.4050. BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 26.3% to $2.73. Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) gained 23% to $14.65. Tyra Biosciences, Inc. (NASDAQ: TYRA) gained 21.8% to $15.84. Tyra Biosciences announced a $200 million private placement financing. Meta Platforms, Inc. (NASDAQ: META) rose 18.9% to $469.34 as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share. CCSC Technology International Holdings Limited (NASDAQ: CCTG) gained 18.2% to $4.6099 after dipping around 82% on Thursday. Roma Green Finance Limited (NASDAQ: ROMA) gained 15.8% to $0.8697 after gaining around 5% on Thursday. Deckers Outdoor Corporation (NYSE: DECK) surged 14% to $879.03 after reporting better-than-expected third-quarter financial results. Trugolf, Inc. (NASDAQ: TRUG) shares jumped 14% to ...
Benzinga · Feb 2, 2024
Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share. The company also announced a $50 billion increase to its share repurchase authorization. Meta shares climbed 16.5% to $460.02 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers CCSC Technology International Holdings Limited (NASDAQ: CCTG) gained 55.1% to $6.05 in pre-market trading after dipping around 82% on Thursday. Trugolf, Inc. (NASDAQ: TRUG) shares jumped 33.1% to $1.77 in pre-market trading after dipping 55% on Thursday. Roma Green Finance Limited (NASDAQ: ROMA) gained 25.2% to $0.94 in pre-market trading after gaining around 5% on Thursday. Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares gained 20% to $0.84 in pre-market trading. C3is Inc. (NASDAQ: CISS) shares rose 18.8% to $0.1625 in pre-market trading. S.H.N. Financial recently reported a 9.1% stake in the company. Minim, Inc. (NASDAQ: MINM) shares rose 18.7% to $5.97 in pre-market trading after gaining more than 22% on ...
Benzinga · Feb 2, 2024
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company’s quarterly sales came in at $4.20 billion versus estimates of $4.34 billion. C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Minim, Inc. (NASDAQ: MINM) shares climbed 57.3% to $6.45. David E. Lazar recently disclosed a 51% active stake in Minim. Clearmind Medicine Inc. (NASDAQ: CMND) jumped 51% to $2.17. Clearmind Medicine announced long-term licensing agreement with BIRAD. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) climbed 52.9% to $5.00. NeuroBo Pharmaceuticals announced FDA clearance of IND for Phase 1 clinical trial of DA-1726 for the treatment of obesity. FibroBiologics, Inc. (NASDAQ: FBLG) shares climbed 47.4% to $42.90. FibroBiologics announced direct listing on the NASDAQ. Celularity Inc. (NASDAQ: CELU) rose 36% to $0.5191. Celularity said it sees FY24 net sales of $50 million to $56 million. Cimpress plc (NASDAQ: CMPR) jumped 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares. TuSimple Holdings Inc. (NASDAQ: TSP) rose 28% to $0.2950. Elevai Labs, Inc. (NASDAQ: ELAB) gained 23.5% to $0.84 after gaining 8% on Wednesday. Asset Entities Inc. (NASDAQ: ASST) climbed 22.8% to $0.5650. Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares jumped 20.4% to $0.6649. Kiora Pharmaceuticals announced a private placement of up to $45 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 19.5% to $4.70. Evaxion Biotech announced pricing of $15 million public offering of 3.750 million ADS at $4.00 per ADS. Nextracker Inc. (NASDAQ: NXT) rose climbed 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results. SunPower Corporation (NASDAQ: SPWR) jumped 18.1% to $3.5791. BioRestorative Therapies, Inc. (NASDAQ: BRTX) gained 16.4% to $1.8850. Corteva, Inc. (NYSE:
Benzinga · Feb 1, 2024
Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-expected third-quarter financial results. Nextracker reported quarterly earnings of 96 cents per share which beat the analyst consensus estimate of 48 cents by 100%. Revenue clocked in at $710.43 million, topping the Street's estimate of $617.95 million, a 38.38% increase over sales of $513.37 million from the same period last year, according to data from Benzinga Pro. Nextracker shares surged 19.7% to $54.20 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Elevai Labs, Inc. (NASDAQ: ELAB) gained 85.3% to $1.26 in pre-market trading after gaining 8% on Wednesday. Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares jumped 52.1% to $0.8420 in pre-market trading. Kiora Pharmaceuticals announced a private placement of up to $45 million. Oragenics, Inc. (NYSE: OGEN) gained 17.6% to $2.71 in pre-market trading after dipping around 34% on Wednesday. Oragenics recently announced termination of at-market offering program. TROOPS, Inc. (NASDAQ: TROO) shares gained 14.8% to $2.16 in pre-market ...
Benzinga · Feb 1, 2024
Analyst Expectations for Kiora Pharmaceuticals's Future
Analysts have provided the following ratings for Kiora Pharmaceuticals (NASDAQ:KPRX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 3 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Kiora Pharmaceuticals has an average price target of $2.38 with a high of $3.50 and a low of $2.00. Below is a summary of how these 4 analysts rated Kiora Pharmaceuticals ...Full story available on Benzinga.com
Benzinga · Nov 6, 2023
Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Electriq Power Holdings, Inc. (NYSE: ELIQ) shares jumped 130.3% to $3.3847. Bruush Oral Care Inc. (NASDAQ: BRSH) shares jumped 102% to $3.5007 after falling 50% on Wednesday. VinFast Auto Ltd. (NASDAQ: VFS) gained 40% to $51.79. Nemaura Medical Inc. (NASDAQ: NMRD) climbed 29.6% to $0.5317. TDCX Inc. (NYSE: TDCX) surged 29.4% to $6.18 following second-quarter earnings. Guess?, Inc. (NYSE: GES) climbed 27% to $23.26 after the company reported better-than-expected second-quarter results and issued above-consensus FY24 EPS guidance. ESGL Holdings Limited (NASDAQ: ESGL) gained 22% to $1.90. Backblaze, Inc. (NASDAQ: BLZE) rose 17% to $5.16 as the company raised its FY23 revenue outlook. OSI Systems, Inc. (NASDAQ: OSIS) jumped 15.5% to $138.84. OSI Systems reported fourth-quarter revenue growth of 22% year-over-year to $411.9 million, beating the consensus of $384.5 million. The Glimpse Group, Inc. (NASDAQ: VRAR) gained 15% to $3.33. Build-A-Bear Workshop, Inc. (NYSE: BBW) rose 13.9% to $27.79 after the company reported better-than-expected second-quarter financial results and issued guidance. Splunk Inc. (NASDAQ: SPLK) shares rose 13.3% to $113.24 after the company reported better-than-expected second-quarter financial results and issued FY24 revenue guidance above estimates. Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) climbed 13% to $0.4996. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) gained 12.7% to $0.1690 after falling over 15% on Wednesday. SharkNinja, Inc. (NYSE: SN) rose 12.5% to $35.98 after the company reported a year-over-year increase in second-quarter financial results and issued guidance. Aviat Networks, Inc. (NASDAQ: AVNW) jumped 12.4% to $32.10 following strong quarterly results. Groupon, ...
Benzinga · Aug 24, 2023
Why Opera Shares Are Trading Lower By Around 12%; Here Are 20 Stocks Moving Premarket
Gainers Bruush Oral Care Inc. (NASDAQ: BRSH) shares gained 45.1% to $2.51 in pre-market trading after falling 50% on Wednesday. Esports Entertainment Group, Inc. (NASDAQ: GMBL) shares surged 29.4% to $0.1786 in pre-market trading after declining 9% on Wednesday. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) rose 26.3% to $0.1895 in pre-market trading after falling over 15% on Wednesday. Hitek Global Inc. (NASDAQ: HKIT) shares rose 19.3% to $40.51 in pre-market trading after gaining 22% on Wednesday. FOXO Technologies Inc. (NYSE: FOXO) shares climbed 18.5% to $0.1539 in pre-market trading. Foxo Technologies, said on Aug 23, that the company entered into three separate stock purchase agreements, with three accredited investors. Guess?, Inc. (NYSE: GES) rose 17.6% to $21.55 in pre-market trading after the company reported better-than-expected second-quarter results and issued above-consensus FY24 EPS guidance. Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares gained 13% to $0.2520 ...
Benzinga · Aug 24, 2023
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
KP
KPRX
Kiora Pharmaceuticals, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
KPRX
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any KPRX yet.
Related Tickers
Earnings